Skip to search.
 STI Down 0.38%

Becton, Dickinson and Company (BDX)

-NYSE
173.67 Down 1.19(0.68%) 23 Jul 04:01 SGT
Prev Close:174.86
Open:174.65
Bid:173.63 x 1000
Ask:173.65 x 300
1y Target Est:182.00
Beta:1.01394
Next Earnings Date: 4-Aug-16BDX Earnings announcement
Day's Range:172.02 - 174.73
52wk Range:128.87 - 177.50
Volume:638,856
Avg Vol (3m):928,864
Market Cap:36.85B
P/E (ttm):46.42
EPS (ttm):3.74
Div & Yield:2.64 (1.52%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BDXDown 0.68%36.85B
BAXUp 0.48%25.58B
ABTUp 0.30%63.42B

Key Statistics

Forward P/E (1 yr):18.32
P/S (ttm):3.03
Ex-Dividend Date:07-Jun-16

Analysts

Annual EPS Est (Sep-16) :8.57
Quarterly EPS Est (Jun-16) :2.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback